Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$39M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 21 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 44 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Aug 7 | RPRX | Royalty Pharma plc | GGIFT◆ | 18,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 5 | RPRX | Royalty Pharma plc | AGRANT | 11,002 | — | — | — | Open the original filing on SEC.gov |
| May 26 | RPRX | Royalty Pharma plc | SSELL◷ | 64,399 | $53.98 | $3.5M | -100.0% | Open the original filing on SEC.gov |
| May 6 | RPRX | Royalty Pharma plc | AGRANT | 24,263 | — | — | +60.5% | Open the original filing on SEC.gov |
| Apr 28 | RPRX | Royalty Pharma plc | SSELL◷ | 1,875 | $49.78 | $93.3K | -4.5% | Open the original filing on SEC.gov |
| Apr 28 | RPRX | Royalty Pharma plc | SSELL◷ | 32,916 | $49.78 | $1.6M | -100.0% | Open the original filing on SEC.gov |
| Apr 1 | RPRX | Royalty Pharma plc | SSELL◷ | 32,916 | $48.33 | $1.6M | -50.0% | Open the original filing on SEC.gov |
| Apr 1 | RPRX | Royalty Pharma plc | SSELL◷ | 1,875 | $48.33 | $90.6K | -4.3% | Open the original filing on SEC.gov |
| Mar 23 | RPRX | Royalty Pharma plc | SSELL◷ | 1,875 | $45.53 | $85.4K | -4.1% | Open the original filing on SEC.gov |
| Mar 23 | RPRX | Royalty Pharma plc | SSELL◷ | 32,916 | $45.53 | $1.5M | -33.3% | Open the original filing on SEC.gov |
| Mar 2 | RPRX | Royalty Pharma plc | SSELL◷ | 583 | $47.01 | $27.4K | -1.3% | Open the original filing on SEC.gov |
| Mar 2 | RPRX | Royalty Pharma plc | SSELL◷ | 1,292 | $46.67 | $60.3K | -2.7% | Open the original filing on SEC.gov |
| Mar 2 | RPRX | Royalty Pharma plc | SSELL◷ | 10,429 | $47.01 | $490.3K | -9.6% | Open the original filing on SEC.gov |
| Mar 2 | RPRX | Royalty Pharma plc | SSELL◷ | 22,487 | $46.67 | $1M | -17.1% | Open the original filing on SEC.gov |
| Feb 23 | RPRX | Royalty Pharma plc | SSELL◷ | 1,875 | $45.32 | $85K | -3.8% | Open the original filing on SEC.gov |
| Feb 23 | RPRX | Royalty Pharma plc | SSELL◷ | 32,916 | $45.32 | $1.5M | -20.0% | Open the original filing on SEC.gov |
| Feb 11 | RPRX | Royalty Pharma plc | AGRANT | 26,626 | — | — | +116.3% | Open the original filing on SEC.gov |
| Feb 4 | RPRX | Royalty Pharma plc | SSELL◷ | 1,087 | $43.29 | $47.1K | -4.5% | Open the original filing on SEC.gov |
| Feb 4 | RPRX | Royalty Pharma plc | SSELL◷ | 19,076 | $43.29 | $825.9K | -10.4% | Open the original filing on SEC.gov |
| Feb 3 | RPRX | Royalty Pharma plc | SSELL◷ | 6,195 | $42.84 | $265.4K | -20.5% | Open the original filing on SEC.gov |
| Feb 3 | RPRX | Royalty Pharma plc | SSELL◷ | 108,759 | $42.84 | $4.7M | -37.2% | Open the original filing on SEC.gov |
| Feb 2 | RPRX | Royalty Pharma plc | SSELL◷ | 5,843 | $42.08 | $245.9K | -16.2% | Open the original filing on SEC.gov |
| Feb 2 | RPRX | Royalty Pharma plc | SSELL◷ | 102,581 | $42.08 | $4.3M | -26.0% | Open the original filing on SEC.gov |
| Jan 20 | RPRX | Royalty Pharma plc | SSELL◷ | 3,750 | $39.35 | $147.6K | -9.4% | Open the original filing on SEC.gov |
| Jan 20 | RPRX | Royalty Pharma plc | SSELL◷ | 65,832 | $39.35 | $2.6M | -14.3% | Open the original filing on SEC.gov |
| Jan 2 | RPRX | Royalty Pharma plc | SSELL◷ | 3,750 | $38.42 | $144.1K | -8.6% | Open the original filing on SEC.gov |
| Jan 2 | RPRX | Royalty Pharma plc | SSELL◷ | 65,832 | $38.42 | $2.5M | -12.5% | Open the original filing on SEC.gov |
| Dec 15, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 3,750 | $38.36 | $143.9K | -7.9% | Open the original filing on SEC.gov |
| Dec 15, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 65,832 | $38.36 | $2.5M | -11.1% | Open the original filing on SEC.gov |
| Dec 1, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 3,750 | $39.87 | $149.5K | -7.3% | Open the original filing on SEC.gov |
| Dec 1, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 65,832 | $39.87 | $2.6M | -10.0% | Open the original filing on SEC.gov |
| Nov 24, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 624 | $37.96 | $23.7K | -1.2% | Open the original filing on SEC.gov |
| Nov 24, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 3,126 | $38.67 | $120.9K | -5.7% | Open the original filing on SEC.gov |
| Nov 24, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 10,686 | $37.96 | $405.6K | -1.6% | Open the original filing on SEC.gov |
| Nov 24, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 55,146 | $38.67 | $2.1M | -7.6% | Open the original filing on SEC.gov |
| Nov 17, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 3,750 | $39.30 | $147.4K | -6.4% | Open the original filing on SEC.gov |
| Nov 17, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 65,844 | $39.30 | $2.6M | -8.3% | Open the original filing on SEC.gov |
| Nov 5, 2025 | RPRX | Royalty Pharma plc | AGRANT | 6,168 | — | — | +11.8% | Open the original filing on SEC.gov |
| Aug 8, 2025 | RPRX | Royalty Pharma plc | GGIFT◆ | 1,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 6, 2025 | RPRX | Royalty Pharma plc | AGRANT | 3,696 | — | — | +7.6% | Open the original filing on SEC.gov |
| May 16, 2025 | RPRX | Royalty Pharma plc | AGRANT◆ | 1.8M | — | — | — | Open the original filing on SEC.gov |
| May 8, 2025 | RPRX | Royalty Pharma plc | AGRANT | 48,646 | — | — | — | Open the original filing on SEC.gov |